Bullseye Breakdown - Ep. 111 - Brian Feth - Scaling Cell Therapy and Using AI to Fight Cancer
What if cancer could be treated using your own supercharged immune cells?
In this episode of Bullseye Breakdown , host Dustin Weaver sits down with Brian Feth , CEO of Xcellbio , to unpack the future of cancer treatment through immune cell therapy , AI-driven potency testing , and scalable biotech manufacturing .
We cover:
-
How CAR-T therapies are shifting from “last resort” to front-line treatment
-
Why scaling biotech is like surgery — not software
-
How AI and impedance readers are changing the way we measure cancer-fighting potency
-
Building a platform that helps cure patients and generate revenue before FDA approval
-
The emotional toll of biotech — and how to lead through it
Brian also shares the worst advice he ever received, and how his team has built a company that’s saving lives — and scaling with grit.
If you care about cancer research , biotech startups , or what it takes to grow a mission-driven business in a brutal industry, this one’s a must-listen.
🎯 Follow Bullseye Breakdown for unfiltered founder stories that aim higher.
